Polydex Updates Company Website www.Polydex.com
25 June 2013 - 11:00PM
Polydex Pharmaceuticals Limited (Pink
Sheets:POLXF) (the "Company") has updated the company website at
www.Polydex.com with an aim to provide greater transparency and
other helpful information to shareholders, investors and interested
parties alike.
The company's new website includes greater access to financial
reports, recent news releases and company information as it becomes
available, and includes links to current stock quotes and charts.
Shareholders and visitors can also subscribe to receive News
Releases directly from the Company website.
Information on the company's product line is available at
www.Dextran.ca.
Polydex Pharmaceuticals Limited, based in Toronto, Ontario,
Canada, is engaged in the development, manufacture and marketing of
biotechnology-based products for the human pharmaceutical market,
and also manufactures bulk pharmaceutical intermediates for the
worldwide veterinary pharmaceutical industry.
Note: This press release may contain forward-looking statements,
within the meaning of the United States Securities Act of 1933, as
amended, and the United States Securities Exchange Act of 1934, as
amended, regarding Polydex Pharmaceuticals Limited, including,
without limitation, statements regarding expectations about future
revenues or business opportunities or potential research projects.
These statements are typically identified by use of words like
"may", "could", "might", "expect", "anticipate", "believe", or
similar words. Actual events or results may differ materially from
the Company's expectations, which are subject to a number of known
and unknown risks and uncertainties including but not limited to
changing market conditions, future actions by the United States
Food and Drug Administration or equivalent foreign regulatory
authorities as results of pending or future clinical trials. Other
risk factors discussed in the Company's quarterly reports may also
affect the actual results achieved by the Company.
CONTACT: Investor Relations: North Arm Capital Services,
Linda Hughes, 1-877-945-1621, (Linda@northarm.com)
Polydex Pharmaceuticals (PK) (USOTC:POLXF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Polydex Pharmaceuticals (PK) (USOTC:POLXF)
Historical Stock Chart
From Jul 2023 to Jul 2024